• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Relay Therapeutics Inc (NQ: RLAY )

    6.760 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 6.760
    Bid (Size) 2.730 (1)
    Ask (Size) 8.750 (3)
    Prev. Close 6.760
    Today's Range 6.760 - 6.760
    52wk Range 5.700 - 12.14
    Shares Outstanding 121,613,181
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
    The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030. 
    Via Talk Markets
    Expert Ratings For Relay Therapeutics
    Via Benzinga

    Performance

    YTD
    -42.98%
    -42.98%
    1 Month
    -18.26%
    -18.26%
    3 Month
    +7.30%
    +7.30%
    6 Month
    -32.53%
    -32.53%
    1 Year
    -36.47%
    -36.47%

    More News

    Read More
    RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024
    Via InvestorPlace
    Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Expert Ratings For Relay Therapeutics
    Via Benzinga
    Expert Ratings For Relay Therapeutics
    Via Benzinga
    AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
    Via Talk Markets
    These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD
    Via Talk Markets
    Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
    Via Talk Markets
    Clinical-Stage BioTech Drug Stocks Declined 13% In June
    Via Talk Markets
    Key Takeaways From Relay Therapeutics Analyst Ratings
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined 6%
    Via Talk Markets
    AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
    Via Talk Markets
    AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
    Via Talk Markets
    Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
    Via Talk Markets
    Relay Therapeutics to Participate in Upcoming Investor Conferences
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
    From Relay Therapeutics, Inc.
    Via GlobeNewswire
    5 Of 7 AI Categories Rose, Slightly,Over Past Week
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    The 7 AI Categories Declined, On Average, The First Week Of May
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
    Via Talk Markets
    RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.